Effect of metformin on the incidence of head and neck cancer in diabetics

Head and Neck

Volumn 37, Issue 9, 2015, Pages 1268-1273

  Yen, Yung Chang ^a   Lin, Charlene ^b   Lin, Shih Wei ^c   Lin, Yung Song ^d,e   Weng, Shih Feng ^e,f  

^a Chi Mei Medical Centre   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

^f CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

diabetes; head and neck cancer; metformin; nasopharyngeal carcinoma; oral cancer

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HAZARD RATIO; HEAD AND NECK CANCER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OBESITY; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGE DISTRIBUTION; CASE CONTROL STUDY; COMORBIDITY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HEAD AND NECK NEOPLASMS; INCIDENCE; MIDDLE AGED; PATHOLOGY; POISSON DISTRIBUTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEX RATIO; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; METFORMIN; MIDDLE AGED; POISSON DISTRIBUTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME;

EID: 84938994745     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23743     Document Type: Article

References (27)

1. Leone A, Di Gennaro E, Bruzzese F, Avallone A, Budillon A,. New perspective for an old antidiabetic drug: metformin as anticancer agent. Cancer Treat Res 2014; 159: 355-376.
2. Franciosi M, Lucisano G, Lapice E, Strippoli GF, Pellegrini F, Nicolucci A,. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PloS One 2013; 8: e71583.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
4. Vitale-Cross L, Molinolo AA, Martin D, et al., Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions. Cancer Prev Res (Phila) 2012; 5: 562-573.
5. Sikka A, Kaur M, Agarwal C, Deep G, Agarwal R,. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. Cell Cycle 2012; 11: 1374-1382.
6. Patel H, Younis RH, Ord RA, Basile JR, Schneider A,. Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin. J Oral Pathol Med 2013; 42: 250-256.
7. Sandulache VC, Hamblin JS, Skinner HD, Kubik MW, Myers JN, Zevallos JP,. Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma. Head Neck 2013. [Epub ahead of print].
8. Argiris A, Karamouzis MV, Raben D, Ferris RL,. Head and neck cancer. Lancet 2008; 371: 1695-1709.
9. Rubin DB,. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127(8 Pt 2): 757-763.
10. Neville BW, Day TA,. Oral cancer and precancerous lesions. CA Cancer J Clin 2002; 52: 195-215.
11. La Vecchia C, Lucchini F, Negri E, Levi F,. Trends in oral cancer mortality in Europe. Oral Oncol 2004; 40: 433-439.
12. Mazzone PJ, Rai H, Beukemann M, Xu M, Jain A, Sasidhar M,. The effect of metformin and thiazolidinedione use on lung cancer in diabetics. BMC Cancer 2012; 12: 410.
13. Zhang ZJ, Li S,. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 2014. [Epub ahead of print].
14. Yin M, Zhou J, Gorak EJ, Quddus F,. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist 2013; 18: 1248-1255.
15. Wang P, Kang D, Cao W, Wang Y, Liu Z,. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 2012; 28: 109-122.
16. Shikata K, Ninomiya T, Kiyohara Y,. Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 2013; 104: 9-14.
17. Giovannucci E, Harlan DM, Archer MC, et al., Diabetes and cancer: a consensus report. CA Cancer J Clin 2010; 60: 207-221.
18. Lann D, LeRoith D,. The role of endocrine insulin-like growth factor-I and insulin in breast cancer. J Mammary Gland Biol Neoplasia 2008; 13: 371-379.
19. Malek M, Aghili R, Emami Z, Khamseh ME,. Risk of cancer in diabetes: the effect of metformin. ISRN Endocrinol 2013; 2013: 636927.
20. Qaseem A, Humphrey LL, Sweet DE, et al., Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2012; 156: 218-231.
21. Raz I,. Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care 2013; 36 Suppl 2: S139-S144.
22. Novosyadlyy R, LeRoith D,. Hyperinsulinemia and type 2 diabetes: impact on cancer. Cell Cycle 2010; 9: 1449-1450.
23. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE,. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000; 21: 215-244.
24. LeRoith D, Roberts CT Jr,. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195: 127-137.
25. Gatenby RA, Gillies RJ,. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
26. Lorenzi M, Montisano DF, Toledo S, Barrieux A,. High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest 1986; 77: 322-325.
27. Robertson R, Zhou H, Zhang T, Harmon JS,. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys 2007; 48: 139-146.